FIELD: biotechnology.
SUBSTANCE: invention relates to a simple and effective method of correcting thymus mass and cellularity. As an agent for inhibiting thymic involution in tumour growth, proposed is the use of zinc sulphate with drinking water orally in dosage of 33 mcg per 1 ml of drinking water for three weeks.
EFFECT: invention can be used to inhibit thymus involution and increase cellularity of this organ in tumour growth.
1 cl, 7 dwg
Title | Year | Author | Number |
---|---|---|---|
AGENT SHOWING IMMUNOMODULATING ACTIVITY | 1994 |
|
RU2080120C1 |
METHOD FOR PROLONGING LIFESPAN OF EXPERIMENTAL ANIMALS | 2017 |
|
RU2666686C1 |
METHOD FOR PREDICTING EFFICACY OF CYTOSTATIC CHEMOTHERAPY IN PATIENTS SUFFERING MALIGNANT NEW GROWTHS OF EPITHELIAL TISSUES | 2014 |
|
RU2546533C9 |
PREPARATION STIMULATING THE DIFFERENTIATION OF T-LYMPHOCYTES | 2001 |
|
RU2188032C1 |
COMPOSITION CONTAINING PIC FOR CANCER TREATMENT | 2017 |
|
RU2728175C2 |
RECOMBINANT STREPTOCOCCUS PYOGENES (pT7ErmEMM) STRAIN - TUMOR GROWTH INHIBITOR | 2016 |
|
RU2685947C2 |
METHOD FOR TREATING MALIGNANT TUMORS IN ANIMALS | 2006 |
|
RU2317825C1 |
THYMUS-SPECIFIC PROTEIN | 2005 |
|
RU2535971C2 |
TETRAPEPTIDE STIMULATING FUNCTIONAL ACTIVITY OF HEPATOCYTES, PHARMACOLOGICAL AGENT BASED ON THEREOF AND METHOD OF ITS USE | 2000 |
|
RU2166957C1 |
APPLICATION OF PROTEIN EXTRACT AS ANTIPROLIFERATIVE AND CYTOTOXIC AGENT | 2017 |
|
RU2671632C1 |
Authors
Dates
2024-05-28—Published
2021-08-11—Filed